News
After decades of working in parallel worlds of sculpture and fiction, Barbara Chase-Riboud is achieving deserved worldwide ...
Intellia’s stock fell 23% after one patient in its Phase III MAGNITUDE trial developed severe liver toxicity that later ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results